Literature DB >> 28009737

Clinicopathological Features of Cervical Esophageal Cancer: Retrospective Analysis of 63 Consecutive Patients Who Underwent Surgical Resection.

Hiroshi Saeki1, Satoshi Tsutsumi, Takafumi Yukaya, Hirotada Tajiri, Ryosuke Tsutsumi, Sho Nishimura, Yu Nakaji, Kensuke Kudou, Shingo Akiyama, Yuta Kasagi, Yuichiro Nakashima, Masahiko Sugiyama, Hideto Sonoda, Kippei Ohgaki, Eiji Oki, Ryuji Yasumatsu, Torahiko Nakashima, Masaru Morita, Yoshihiko Maehara.   

Abstract

OBJECTIVE: The objectives of this retrospective study were to elucidate the clinicopathological features and recent surgical results of cervical esophageal cancer. SUMMARY BACKGROUND DATA: Cervical esophageal cancer has been reported to have a dismal prognosis. Accurate knowledge of the clinical characteristics of cervical esophageal cancer is warranted to establish appropriate therapeutic strategies.
METHODS: The clinicopathological features and treatment results of 63 consecutive patients with cervical esophageal cancer (Ce group) who underwent surgical resection from 1980 to 2013 were analyzed and compared with 977 patients with thoracic or abdominal esophageal cancer (T/A group) who underwent surgical resection during that time.
RESULTS: Among the patients who received curative resection, the 5-year overall and disease-specific survival rates of the Ce patients were significantly better than those of the T/A patients (overall: 77.3% vs 46.5%, respectively, P = 0.0067; disease-specific: 81.9% vs 55.8%, respectively, P = 0.0135). Although total pharyngo-laryngo-esophagectomy procedures were less frequently performed in the recent period, the rate of curative surgical procedures was markedly higher in the recent period (2000-1013) than that in the early period (1980-1999) (44.4% vs 88.9%, P = 0.0001). The 5-year overall survival rate in the recent period (71.5%) was significantly better than that in the early period (40.7%, P = 0.0342).
CONCLUSIONS: Curative resection for cervical esophageal cancer contributes to favorable outcomes compared with other esophageal cancers. Recent surgical results for cervical esophageal cancer have improved, and include an increased rate of curative resection and decreased rate of extensive surgery.

Entities:  

Mesh:

Year:  2017        PMID: 28009737     DOI: 10.1097/SLA.0000000000001599

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

Review 1.  Cervical Esophageal Cancers: Challenges and Opportunities.

Authors:  Michael Buckstein; Jerry Liu
Journal:  Curr Oncol Rep       Date:  2019-04-04       Impact factor: 5.075

2.  Oncological outcomes of cervical esophageal cancer treated primarily with surgery: a systematic review and meta-analysis.

Authors:  Armando De Virgilio; Andrea Costantino; Carlo Castoro; Giuseppe Spriano; Bianca Maria Festa; Giuseppe Mercante; Davide Franceschini; Ciro Franzese; Marta Scorsetti; Andrea Marrari; Raffaele Cavina; Salvatore Marano
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-15       Impact factor: 3.236

3.  Prognostic impact of MutT homolog-1 expression on esophageal squamous cell carcinoma.

Authors:  Shingo Akiyama; Hiroshi Saeki; Yuichiro Nakashima; Makoto Iimori; Hiroyuki Kitao; Eiji Oki; Yoshinao Oda; Yusaku Nakabeppu; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Cancer Med       Date:  2016-12-05       Impact factor: 4.452

4.  Clinicopathological features and surgical treatment of cervical oesophageal cancer.

Authors:  Shao-Bin Chen; Xi-Hong Yang; Hong-Rui Weng; Di-Tian Liu; Hua Li; Yu-Ping Chen
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

5.  Efficacy and safety of endoscopic submucosal dissection for superficial cancer of the cervical esophagus.

Authors:  Toshiro Iizuka; Daisuke Kikuchi; Shu Hoteya; Yoshiaki Kajiyama; Mitsuru Kaise
Journal:  Endosc Int Open       Date:  2017-08-07

6.  The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study.

Authors:  Jing Hu; Zhe Chen; Jiaming Lv; Zhen Zheng; Yanping Bei; Xue Chen; Lu Zheng; Wenjie Song; Yunbao Xu
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

7.  Home enteral nutrition for patients with esophageal cancer undergoing esophagectomy: A systematic review and meta-analysis.

Authors:  Chi Zhang; Li-Wen Hu; Yong Qiang; Zhuang-Zhuang Cong; Chao Zheng; Wen-Feng Gu; Chao Luo; Kai Xie; Yi Shen
Journal:  Front Nutr       Date:  2022-07-28

8.  Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer.

Authors:  Jun Hou; Yinfeng Yang; Honglei Gao; Ting Ouyang; Qiwei Liu; Ran Ding; Hongxing Kan
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

9.  Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes.

Authors:  Peinan Chen; Xueke Zhao; Fuyou Zhou; Xin Song; Shoujia Hu; Yan Jin; Xianzeng Wang; Xuena Han; Zongmin Fan; Ran Wang; Bei Li; Wenli Han; Panpan Wang; Jilin Li; Lixin Wan; Liguo Zhang; Qide Bao; Fubao Chang; Yanru Qin; Zhiwei Chang; Jianwei Ku; Haijun Yang; Ling Yuan; Jingli Ren; Xuemin Li; Lidong Wang
Journal:  Cancer Biol Med       Date:  2020-02-15       Impact factor: 4.248

10.  Clinicopathological features and prognosis of patients with esophageal cancer as the second primary cancer: a large population-based analysis using the SEER program [2000-2015].

Authors:  Zhencong Chen; Ming Li; Ke Ma; Zhengyang Hu; Shuai Wang; Hongyu Chen; Yuansheng Zheng; Cheng Zhan; Zongwu Lin; Qun Wang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.